Home/Filings/5/0000950170-25-010531
5//SEC Filing

Betz Stephen F. 5

Accession 0000950170-25-010531

CIK 0001658247other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 4:30 PM ET

Size

4.8 KB

Accession

0000950170-25-010531

Insider Transaction Report

Form 5
Period: 2024-12-31
Betz Stephen F.
Chief Scientific Officer
Transactions
  • Other

    Common Stock

    2024-11-20$14.98/sh+451$6,75671,358 total
Footnotes (1)
  • [F1]Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),

Documents

1 file

Issuer

Crinetics Pharmaceuticals, Inc.

CIK 0001658247

Entity typeother

Related Parties

1
  • filerCIK 0001886575

Filing Metadata

Form type
5
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:30 PM ET
Size
4.8 KB